Back
Essilorluxottica Vs. Innate Pharma SA Industry Stock Comparison
Buy
68
ESLOY
Essilorluxottica
Last Price:
122.28
Seasonality Move:
3.14%
Sell
10
IPHA
Innate Pharma SA
Last Price:
1.82
Seasonality Move:
9.13%
Buy
68
Essilorluxottica (ESLOY)
is a Buy
Is Essilorluxottica a Buy, Sell or Hold?
- The current Essilorluxottica [ESLOY] share price is $122.28. The Score for ESLOY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- ESLOY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
10
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.78. The Score for IPHA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $122.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESLOY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESLOY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 65.87 | Buy |
| Chaikin Money Flow: | 16302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.9 - 119.18) | Buy |
| Bollinger Bands (100): | (110 - 118.42) | Buy |
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 38.09 | Sell |
| Chaikin Money Flow: | 4049 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.84 - 2.12) | Sell |
| Bollinger Bands (100): | (1.99 - 2.29) | Sell |
ESLOY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 118.29 | Buy |
| 20-day SMA: | 117.9 | Buy |
| 50-day SMA: | 117.08 | Buy |
| 200-day SMA: | 111.19 | Buy |
| 8-day EMA: | 119.06 | Buy |
| 20-day EMA: | 118.06 | Buy |
| 50-day EMA: | 116.8 | Buy |
| 200-day EMA: | 110.87 | Buy |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Sell |
| 20-day SMA: | 1.93 | Sell |
| 50-day SMA: | 2.12 | Sell |
| 200-day SMA: | 2.36 | Sell |
| 8-day EMA: | 1.84 | Sell |
| 20-day EMA: | 1.92 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 2.32 | Sell |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Essilorluxottica Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Innate Pharma SA Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||